Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox in Post-stroke Upper Limb Spasticity
NCT01153815Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2010
- Primary completion
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Upper limb spasticity comparing Botox with Placebo (2 arms). Primary endpoint: Change From Baseline at Week 6 for Wrist Flexor Muscle Tone as Measured on the Modified Ashworth Scale. Started Apr 2010; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Upper limb spasticity
Beyond the preview
Go deeper on NCT01153815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01153815.